I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Laparoscopic cholecystectomy (LC) has been pursued in comparison to open surgery and has become the gold standard since its first inception in 1987.\[[@ref1]\] The advantages offered include small scar, short surgery, and early discharge from the hospital.\[[@ref2]\] Though the cost is slightly higher due to the use of specified instruments and the technique, the insurance coverage makes it a relatively affordable surgery. However, pneumoperitoneum is a common side effect of LC, which is required for a proper visualization of the surgical area and certain operative manipulations.

Pneumoperitoneum affects several homeostatic systems leading to alteration in acid-base balance, cardiovascular, pulmonary physiology and stress response such as increase in mean arterial pressure (MAP), decrease in cardiac output, and increase in systemic vascular resistance which causes decreased tissue perfusion.\[[@ref3][@ref4]\] The relative chances of such hemodynamic disturbances during LC are much higher as compared to other types of laparoscopic surgeries due to the unique steep head-up position which is required to be maintained during LC. In addition to the creation of the pneumoperitoneum, endotracheal intubation as required during LC is also an invasive procedure that may cause intense autonomic response. Tachycardia, hypertension, arrhythmias, and myocardial ischemia are induced by intubation.\[[@ref3]\]

The primary aim of the anesthetic management during such surgeries is to stabilize the hemodynamic parameters including heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), and MAP along with optimal levels of analgesia.\[[@ref5]\]

The increasing demand of LC led to surge in the search for pharmacological agents that may help stabilize the HR and BP in response to pneumoperitoneum and intubation. Many drugs including opioids, local anesthetics, adrenergic blocking drugs, and vasodilators have been used to attenuate the response but attained a variable success rate with few disadvantages such as headaches and prolonged anesthesia leading to delayed discharge.\[[@ref3][@ref6][@ref7]\]

Pregabalin and clonidine are the two drugs which have been studied widely for postoperative analgesia, but there are very few studies that evaluated their use as oral premedication for attenuation of pressor response.\[[@ref8][@ref9][@ref10]\]

Clonidine is a selective α2 agonist, which is opioid sparing and decreases HR and blood pressure. It has been used for attenuating vasopressor responses in previous observational studies.\[[@ref11][@ref12][@ref13]\] Pregabalin, on the other hand, is a derivative of the neurotransmitter γ aminobutyric acid (GABA) that possess analgesic, anxiolytic, anticonvulsant, and hemodynamic stabilizing properties.\[[@ref14][@ref15][@ref16]\] Both drugs can be given orally and are equally good, but the definitive choice among the two remains a matter of choice by the anesthesiologist rather than on evidence-based results.

The present study was thus conducted to study the efficacy of oral premedication with pregabalin or clonidine on changes in HR and mean arterial blood pressure during laryngoscopy and laparoscopy, along with perioperative hemodynamic stability.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
=================================================

The prospective, interventional, randomized, comparative, single-blinded study was conducted in the department of anesthesia and surgery from January 2015 to September 2016. Approval was taken from the institutional ethical committee. After taking written informed consent from the patients, a total of 90 American Society of Anaesthesiologists (ASA) Grade I or II normotensive patients aged 18--56 years and scheduled for elective surgery under general anesthesia were recruited for the randomized comparative study.

Block randomization with sealed envelope system was chosen to randomize the study patients. Fifteen randomly generated treatment allocations within sealed opaque envelopes assigning A, B, and C in 5 envelopes each were prepared, where A represented oral pregabalin group, B represented oral clonidine group, and C represented control group. Once a patient gave consent to enter a trial, an envelope was opened, and the patient was offered the allocated group. In this technique, patients were randomized in a series of blocks of fifteen. The patient was not aware as to which treatment he/she is getting, making the study single blinded.

The patients were assigned randomly into either of following groups with each group comprising 30 patients:

Group A patients received preoperative oral pregabalin 150 mg 1 h before surgeryGroup B patients received preoperative oral clonidine 200 μg 1 h before surgeryGroup C patients did not receive any preoperative drug (control group).

The study of Mrinmoy *et al*.\[[@ref3]\] observed that rise in HR, SBP, DBP, and MAP was 81.26 ± 8.40 bpm, 119.6 ± 10.06 mm Hg, 81.26 ± 8.40 mm Hg, and 93.83 ± 8.107 mm Hg, respectively, in the clonidine group. Taking these values as reference and assuming difference of 10% in change in hemodynamic parameters between clonidine and control/pregabalin, the minimum required sample size with 90% power of study and 5% level of significance is 23 patients in each study group. To reduce margin of error, total sample size taken is 90 (30 patients per group).

Formula used is:

For comparing mean of two groups
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where *Z*~α~ is value of *Z* at two-sided alpha error of 1% and *Z*~β~ is value of Z at power of 90% and mean difference is difference in mean values of two groups.

The following eligibility criteria were followed:

Inclusion criteria {#sec2-1}
------------------

Written informed consent by the patient\'s relativeASA risk I and II.Patients aged 18--56 years of either sexPatients scheduled for elective surgeries under general anesthesia.

Exclusion criteria {#sec2-2}
------------------

Patient refusing to give consentAllergy to pregabalin, clonidinePatients with anticipated difficult intubationPatient having a preexisting neurological disease/seizure disorder or any increased intracranial pressure (hydrocephalus, head injury)Patients under treatment by steroids, nonsteroidal anti-inflammatory drugs or opioids before surgeryASA status III, IV, VEmergency surgeriesPatients with history of asthma, hypertension, diabetes, severe coronary artery disease, myocardial infarction, renal disease, coagulopathy, or bleeding disorder.

On the previous day of surgery, detailed history of the patients was taken; physical examination and routine investigations (complete blood count, renal function test, liver function test, serum electrolytes, chest X-ray, electrocardiogram) were performed. Before 1 h of surgery, Group A patients were given tablet pregabalin 150 mg orally and Group B patients were given tablet clonidine 200 ug orally with a sip of water. Group C patients received none of these. In the operating room, routine monitoring was done. The interventional medications were procured by indenting from the hospital pharmacy and thus were identical. A standard uniform protocol for premedication drugs, induction agents, muscle relaxants, and maintenance of anesthesia were administered in all the patients and the groups.

Patients were induced with fentanyl 3 ug.kg^−1^ and propofol 2 mg.kg^−1^; orotracheal intubation was facilitated by vecuronium 0.08 mg.kg^−1^. Anesthesia was maintained with 100--200 mg.kg^−1^.min^−1^ propofol infusion and 66% nitrous oxide in oxygen. At the end of surgery, residual neuromuscular paralysis was antagonized with neostigmine 0.05 mg.kg^−1^ and glycopyrrolate 0.01 mg.kg^−1^. On the recovery of the patients, they were extubated and taken to the postanesthesia care unit (PACU). In the PACU, patients received intravenous fentanyl via patient controlled analgesia with patient activated dose of 20 mg, lockout interval of 5 min, with a maximum allowable fentanyl dose being 2 g.kg^−1^.h^−1^.

Intraoperatively, HR, MAP, SBP, and DBP levels were monitored and recorded before and after induction, immediately after intubation and 1, 5, and 15 min after laryngoscopy and endotracheal intubation, after insufflation and after 5, 15, 30, and 45 min of insufflation, after exsufflation, at extubation and postop 10 min. Patients were observed for complications and treated as required.

All patients were observed for possible complications or side effects for a minimum period of 24 h postoperatively. Sedation was assessed using the Ramsay Sedation Scale after pretreatment with the study drugs in both the groups. Scoring was done just before induction of anesthesia.

Statistical analysis {#sec2-3}
--------------------

Categorical variables were presented in number and percentage (%) and continuous variables were presented as mean ± standard deviation. Quantitative variables were compared using unpaired *t*-test (when the data sets were not normally distributed) between the two groups. Qualitative variables were compared using Chi-square test/Fisher\'s exact test. *P* \< 0.05 was considered statistically significant. The data were entered into Microsoft EXCEL spreadsheet and analysis were done using Statistical Package for the Social Sciences (SPSS) version 21.0 IBM, Chicago (USA).

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

A total of 90 patients were included in the study. Baseline characteristics are given in [Table 1](#T1){ref-type="table"}. Mean age was 40.8 ± 11.03 years in Group A, 38.4 ± 11.42 years in Group B, and 39.4 ± 12.40 years in Group C. There was no statistically significant difference of age among the 3 groups. Majority of the patients were in ASA Grade 1 in all the groups. The baseline characteristics were comparable among the three groups.

###### 

Comparison of baseline characteristics between Groups A, B and C

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------
  Baseline characteristics        A (*n*=30)           B (*n*=30)          C (*n*=30)        *P*                      95% CI; df
  ------------------------------- -------------------- ------------------- ----------------- ------------------------ -------------------------------------------
   Age (years)                                                                                                        

   18-30, *n*(%)                  6 (20)               9 (30)              8 (26.67)         0.906                    Chi-square test=1.027 (df=4)

   31-40, *n*(%)                  9 (30)               9 (30)              8 (26.67)         A versus B: 0.627        A versus B: Chi-square test=0.933 (df=2)

   41-56, *n*(%)                  15 (50)              12 (40)             14 (46.67)        A versus C: 0.827\       A versus C: Chi-square test=0.379 (df=2)\
                                                                                             B versus C: 0.873        B versus C: Chi-square test=0.271 (df=2)

   Mean±SD                        40.87±11.04          38.3±11.17          39.4±12.4         0.689                    ANOVA; *F*=0.373; df=87

   Median (IQR)                   40.5 (32.75-49.75)   37.5 (28.5-48.75)   40 (27.5-50.75)   A versus B: 0.374        A versus B: −3.172-8.305; df=58

   Range                          23-55                21-56               18-56             A versus C: 0.630\       A versus C: −4.601-7.535; df=58\
                                                                                             B versus C: 0.719        B versus C: −7.199-4.999; df=58

  Gender                                                                                                              

   Female                         21 (70)              23 (76.67)          23 (76.67)        0.792                    Chi-square test=0.467 (df=2)\
                                                                                                                      A versus B: Chi-square test=0.341 (df=1)\
                                                                                                                      A versus C: Chi-square test=0.341 (df=1)\
                                                                                                                      B versus C: Chi-square test=0 (df=1)

   Male                           9 (30)               7 (23.33)           7 (23.33)         A versus B: 0.559\       
                                                                                             A versus C: 0.559\       
                                                                                             B versus C: 1            

  ASA status, *n*(%)                                                                                                  

   I                              27 (90)              25 (83.33)          24 (80)           0.553                    Chi-square test=1.184 (df=2)

   II                             3 (10)               5 (16.67)           6 (20)            A versus B: 0.706\       A versus B: Fisher's exact test\
                                                                                             A versus C: 0.472\       A versus C: Fisher's exact test\
                                                                                             B versus C: 0.739        B versus C: Chi-square test=0.111 (df=1)

  Ramsay sedation score, *n*(%)                                                                                       

   1                              0                    0                   30 (100)          \<0.0001                 Chi-square test=94.737 (df=4)

   2                              27 (90)              30 (100)            0                 A versus B: 0.237        A versus B: Fisher's exact test

   3                              3 (10)               0                   0                 A versus C: \<0.0001xs   A versus C: Chi-square test=60 (df=2)

   4                              0                    0                   0                 B versus C: \<0.0001     B versus C: Fisher's exact test

   5                              0                    0                   0                                          

   6                              0                    0                   0                                          
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------

SD=Standard deviation, IQR=Interquartile range, ASA=American Society of Anaesthesiologists, CI=Confidence interval

On the Ramsay sedation scale, in Group A, 27 patients scored 2; in Group B, all patients scored 2, and in Group C, all 30 patients scored 1. In our study, all the patients were awake irrespective of the groups when they were brought to the operating room.

The values of HR at preinduction, after giving premedication, and at the time of induction were comparable between three groups with no significant difference. There was statistically significant difference in HR during laryngoscopy and intubation, and up to 5 min after that between Group A and Group B, and Group B and Group C. There was statistically significant difference in HR during insufflation and during intraoperative period between Group A and Group C, Group B and Group C, and Group A and Group B. There was no statistically significant difference in HR at time of exsufflation, extubation and in postoperative period between Group A and Group C whereas HR was significantly lower in Group B when compared with Group C \[[Table 2](#T2){ref-type="table"}\].

###### 

Comparison of heart rate (bpm) between Groups A, B and C

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  HR (bpm)               A (*n*=30)           B (*n*=30)         C (*n*=30)           *P*                     95% CI; df
  ---------------------- -------------------- ------------------ -------------------- ----------------------- ----------------------------------------------------------
  Preoperative                                                                                                

   Mean±SD               78.9±10.58           83.43±11.67        80.37±10.53          0.266\                  ANOVA; *F*=1.341; df=87\
                                                                                      A versus B: 0.120\      A versus B: −10.292-1.225; df=58\
                                                                                      A versus C: 0.592\      A versus C: −6.923-3.989; df=58\
                                                                                      B versus C: 0.289       B versus C: −2.678-8.812; df=58

   Median (IQR)          77.5 (71.25-83.75)   86.5 (73-93)       78.5 (72.5-87.75)                            

   Range                 64-113               61-104             61-113                                       

  Premedication                                                                                               

   Mean±SD               82.03±11.23          80.73±9.72         81.13±11.07          0.890\                  ANOVA; *F*=0.116; df=87\
                                                                                      A versus B: 0.633\      A versus B: −4.128-6.728; df=58\
                                                                                      A versus C: 0.755\      A versus C: −4.862-6.662; df=58\
                                                                                      B versus C:0.882        B versus C: −5.783-4.983; df=58

   Median (IQR)          79.5 (74-85)         82.5 (71.75-88)    82 (74-86.75)                                

   Range                 70-120               61-98              61-120                                       

  Induction                                                                                                   

   Mean±SD               85.27±11.65          83.87±9.58         83.73±9.74           0.817\                  ANOVA; *F*=0.201; df=87\
                                                                                      A versus B: 0.613\      A versus B: −4.111-6.911; df=58\
                                                                                      A versus C: 0.582\      A versus C: −4.017-7.083; df=58\
                                                                                      B versus C: 0.957       B versus C: −4.859-5.126; df=58

   Median (IQR)          85 (76.25-91.5)      84 (79-88.75)      83.5 (77.25-90)                              

   Range                 71-120               65-102             65-102                                       

  Laryngoscopy                                                                                                

   Mean±SD               99.77±10.82          93.07±9.64         100.47±9.53          0.008\                  ANOVA; *F*=4.995; df=87\
                                                                                      A versus B: 0.014\      A versus B: 1.404-11.996; df=58\
                                                                                      A versus C: 0.791\      A versus C: −5.968-4.568; df=58\
                                                                                      B versus C:0.004        B versus C: −12.353-−2.447; df=58

   Median (IQR)          98 (95.25-103)       92.5 (86.5-100)    99.5 (95.25-106)                             

   Range                 84-130               71-112             88-130                                       

  1 min                                                                                                       

   Mean±SD               94.47±8.01           89.3±7.95          95.1±9.54            0.018\                  ANOVA; *F*=4.172; df=87\
                                                                                      A versus B: 0.015\      A versus B: 1.041-9.292; df=58\
                                                                                      A versus C: 0.781\      A versus C: −5.185-3.918; df=58\
                                                                                      B versus C: 0.013       B versus C: −10.338-−1.262; df=58

   Median (IQR)          96 (90-98.75)        90 (84-94.75)      95 (90-97.75)                                

   Range                 82-113               74-102             81-118                                       

  5 min                                                                                                       

   Mean±SD               88.53±8.29           84.47±7.86         89.9±8.81            0.036\                  ANOVA; *F*=3.453; df=87\
                                                                                      A versus B: 0.056\      A versus B: -0.11-8.243; df=58\
                                                                                      A versus C: 0.538\      A versus C: −5.788-3.055; df=58\
                                                                                      B versus C: 0.014       B versus C: −9.749-−1.118; df=58

   Median (IQR)          86.5 (84-91.5)       86 (78.5-90)       90 (84-93)                                   

   Range                 76-111               70-100             76-111                                       

  15 min                                                                                                      

   Mean±SD               85.03±7.57           81.9±8.15          85.83±8.42           0.141\                  ANOVA; *F*=1.999; df=87 A versus B: −0.932-7.198; df=58\
                                                                                      A versus B: 0.128\      A versus C: −4.938-3.338; df=58\
                                                                                      A versus C: 0.700\      B versus C: −8.214-0.347; df=58
                                                                                      B versus C: 0.071       

   Median (IQR)          82.5 (80-88.75)      84 (74.5-88)       86 (80-89.75)                                

   Range                 75-103               68-94              71-108                                       

  Insufflation                                                                                                

   Mean±SD               99.83±9.88           92.6±10.33         108.3±10.21          \<0.0001\               ANOVA; *F*=18.012; df=87\
                                                                                      A versus B: 0.007\      A versus B: 2.008-12.458; df=58\
                                                                                      A versus C: 0.001\      A versus C: −13.658-−3.276; df=5\
                                                                                      B versus C: \<0.0001    B versus C: −21.008-−10.392; df=58

   Median (IQR)          98 (93.25-104.75)    93 (83.5-100.25)   110.5 (100-116.25)                           

   Range                 84-122               74-111             89-125                                       

  5 min                                                                                                       

   Mean±SD               96.43±10.81          89.27±10.02        105.07±10.53         \<0.0001\               ANOVA; *F*=17.168; df=87\
                                                                                      A versus B: 0.01\       A versus B: 1.78-12.553; df=58\
                                                                                      A versus C: 0.002\      A versus C: −14.149-−3.118; df=58\
                                                                                      B versus C: \<0.0001    B versus C: −21.112-−10.488; df=58

   Median (IQR)          94.5 (88-102.25)     90 (84-97.25)      105 (97-110)                                 

   Range                 82-117               70-107             87-127                                       

  15 min                                                                                                      

   Mean±SD               93.6±10.32           85.6±9.05          103.53±8.68          0.141\                  ANOVA; *F*=1.999; df=87\
                                                                                      A versus B: 0.128\      A versus B: −0.932-7.198; df=58\
                                                                                      A versus C: 0.7\        A versus C: −4.938-3.338; df=58\
                                                                                      B versus C: 0.071       B versus C: −8.214-0.347; df=58

   Median (IQR)          92 (87-98)           86 (80.25-91.5)    103 (97.25-110)                              

   Range                 80-116               69-105             88-119                                       

  30 min                                                                                                      

   Mean±SD               90.5±9.91            83.87±9.05         102.1±8.61           \<0.0001\               ANOVA; *F*=30.139; df=87\
                                                                                      A versus B: 0.008\      A versus B: 1.728-11.539; df=58\
                                                                                      A versus C: \<0.0001\   A versus C: −16.399-−6.801; df=58\
                                                                                      B versus C: \<0.0001    B versus C: −22.799-−13.668; df=58

   Median (IQR)          89.5 (83.25-94.5)    84 (78.5-88)       101.5 (96.25-109)                            

   Range                 78-115               69-104             89-120                                       

  45 min                                                                                                      

   Mean±SD               89.23±9.62           82.4±8.29          98.97±7.78           \<0.0001\               ANOVA; *F*=28.129; df=87\
                                                                                      A versus B: 0.004\      A versus B: 2.193-11.473; df=58\
                                                                                      A versus C: 0.0001\     A versus C: −14.256-−5.211; df=58\
                                                                                      B versus C: \<0.0001    B versus C: −20.721-−12.412; df=58

   Median (IQR)          88 (84-95)           82 (78.25-86.75)   98.5 (92.25-103)                             

   Range                 75-108               66-98              86-117                                       

  Exsufflation                                                                                                

   Mean±SD               83.53±9.03           79.93±7.68         87.27±6.14           0.001\                  ANOVA; *F*=6.789; df=87\
                                                                                      A versus B: 0.101\      A versus B: −0.733-7.933; df=58\
                                                                                      A versus C: 0.066\      A versus C: −7.724-0.257; df=58\
                                                                                      B versus C: 0.0001      B versus C: −10.927-−3.74; df=58

   Median (IQR)          81.5 (78-87)         80 (72.75-84)      87 (83.25-89.75)                             

   Range                 70-109               68-94              76-100                                       

  Extubation                                                                                                  

   Mean±SD               82.87±8.32           77.3±7.32          82.83±6.13           0.004\                  ANOVA; *F*=5.761; df=87\
                                                                                      A versus B: 0.007\      A versus B: 1.516-9.617; df=58\
                                                                                      A versus C: 0.986\      A versus C: −3.744-3.81; df=58\
                                                                                      B versus C: 0.002       B versus C: −9.023-−2.043; df=58

   Median (IQR)          81 (78-85.75)        77 (70-83)         83.5 (78.25-86.75)                           

   Range                 72-107               66-90              70-98                                        

  Postoperative 10 min                                                                                        

   Mean±SD               79.53±8.41           75.4±7.55          79.6±7.25            0.060\                  ANOVA; *F*=2.892; df=87\
                                                                                      A versus B: 0.049\      A versus B: 0.005-8.262; df=58\
                                                                                      A versus C: 0.973\      A versus C: −4.123-3.99; df=58\
                                                                                      B versus C: 0.031       B versus C: −8.024\--0.376; df=58

   Median (IQR)          78 (74.25-80.75)     74 (70-81)         78.5 (75.25-84.25)                           

   Range                 66-104               63-90              68-97                                        
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------

HR=Heart rate, SD=Standard deviation, IQR=Interquartile range, CI=Confidence interval

The values of SBP at preinduction, after giving premedication and at the time of induction were comparable between three groups with no significant difference. There was statistically significant difference in SBP during laryngoscopy and intubation between Group A and Group B and Group B and Group C. There was statistically significant difference in SBP during insufflation and during intraoperative period between Group A and Group C, Group B and Group C and Group A and Group B. There was no statistically significant difference in SBP at time of exsufflation, extubation between Group A and Group C whereas SBP was significantly lower in Group B when compared with Group A and Group C at the time of exsufflation \[[Table 3](#T3){ref-type="table"}\].

###### 

Comparison of systolic blood pressure (mmHg) between Groups A, B and C

  ------------------------------------------------------------------------------------------------------------------------------------------------------------
  SBP (mmHg)             A (*n*=30)              B (*n*=30)              C (*n*=30)              *P*                     95% CI; df
  ---------------------- ----------------------- ----------------------- ----------------------- ----------------------- -------------------------------------
  Preoperative                                                                                                           

   Mean±SD               123.97±11.77            129.3±15.32             124.67±11.16            0.224\                  ANOVA; *F*=1.518; df=87\
                                                                                                 A versus B: 0.136\      A versus B: −12.395-1.728; df=58\
                                                                                                 A versus C: 0.814\      A versus C: −6.628-5.228; df=58\
                                                                                                 B versus C: 0.185       B versus C: −2.295-11.562; df=58

   Median (IQR)          124 (114-132)           129 (121.5-136)         125 (116.75-133)                                

   Range                 102-145                 93-176                  98-143                                          

  Premedication                                                                                                          

   Mean±SD               123.6±13.82             128.67±14.42            123.77±13.65            0.284\                  ANOVA; *F*=1.274; df=87\
                                                                                                 A versus B: 0.17\       A versus B: −12.366-2.232; df=58\
                                                                                                 A versus C: 0.962\      A versus C: −7.264-6.93; df=58\
                                                                                                 B versus C: 0.181       B versus C: −2.357-12.157; df=58

   Median (IQR)          126.5 (111-131.5)       129.5 (120-136.75)      122.5 (111.75-133.75)                           

   Range                 100-155                 97-167                  100-155                                         

  Induction                                                                                                              

   Mean±SD               123.37±13.24            121.37±12.92            120.57±10.91            0.667\                  ANOVA; *F*=0.406; df=87\
                                                                                                 A versus B: 0.556\      A versus B: −4.763-8.763; df=58\
                                                                                                 A versus C: 0.375\      A versus C: −3.472-9.072; df=58\
                                                                                                 B versus C: 0.796       B versus C: −5.381-6.981; df=58

   Median (IQR)          123 (112-131.25)        121.5 (111-128.75)      122.5 (112-126)                                 

   Range                 103-160                 88-150                  102-145                                         

  Laryngoscopy                                                                                                           

   Mean±SD               142.77±12.44            133.27±15.03            142.3±15.03             0.017\                  ANOVA; *F*=4.255; df=87\
                                                                                                 A versus B: 0.009\      A versus B: 2.369-16.631; df=58\
                                                                                                 A versus C: 0.896\      A versus C: −6.664-7.598; df=58\
                                                                                                 B versus C: 0.023       B versus C: −16.801-−1.266; df=58

   Median (IQR)          141 (136.5-148)         134.5 (123.5-143)       140 (131.5-150.75)                              

   Range                 122-180                 85-161                  111-180                                         

  1 min                                                                                                                  

   Mean±SD               138.43±12.89            132.97±14.38            138.23±14.27            0.228\                  ANOVA; *F*=1.5; df=87\
                                                                                                 A versus B: 0.126\      A versus B: −1.59-12.523; df=58\
                                                                                                 A versus C: 0.954\      A versus C: −6.829-7.229; df=58\
                                                                                                 B versus C:0.159        B versus C: −12.67-2.137; df=58

   Median (IQR)          136 (130.5-146)         134.5 (126-142)         136 (130-145.25)                                

   Range                 113-176                 102-164                 102-176                                         

  5 min                                                                                                                  

   Mean±SD               130.37±11.27            126.63±16.4             128.73±13.31            0.578\                  ANOVA; *F*=0.55; df=87\
                                                                                                 A versus B: 0.309\      A versus B: −3.559-11.026; df=58\
                                                                                                 A versus C: 0.609\      A versus C: −4.739-8.006; df=58\
                                                                                                 B versus C: 0.588       B versus C: −9.818-5.618; df=58

   Median (IQR)          130 (123.25-137.25)     129 (115.25-139.5)      130.5 (122.5-137.5)                             

   Range                 105-162                 82-155                  82-150                                          

  15 min                                                                                                                 

   Mean±SD               125.03±9.62             122.97±14.97            125±11.05               0.751\                  ANOVA; *F*=0.287; df=87\
                                                                                                 A versus B: 0.527\      A versus B: −4.462-8.595; df=58\
                                                                                                 A versus C: 0.990\      A versus C: −5.322-5.389; df=58\
                                                                                                 B versus C: 0.551       B versus C: −8.834-4.768; df=58

   Median (IQR)          127 (119.75-132)        127 (112.5-132)         127 (115.25-133.5)                              

   Range                 104-138                 78-144                  99-143                                          

  Insufflation                                                                                                           

   Mean±SD               143.7±9.98              121.07±12.51            161.73±15.03            \<0.0001                ANOVA; *F*=77.562; df=87

                                                                                                 A versus B: \<0.0001\   A versus B: 16.786-28.481; df=58\
                                                                                                 A versus C: \<0.0001\   A versus C: −24.647-−11.42; df=58\
                                                                                                 B versus C: \<0.0001    B versus C: −47.811-−33.522; df=58

   Median (IQR)          142.5 (136.25-148.5)    122.5 (112.75-130)      164 (147.5-170)                                 

  Range                  129-178                 97-142                  138-202                                         

  5 min                                                                                                                  

  Mean±SD                143.4±8.7               118.67±13.86            161.57±15.76            \<0.0001\               ANOVA; *F*=80.838; df=87\
                                                                                                 A versus B: \<0.0001\   A versus B: 18.729-30.738; df=58\
                                                                                                 A versus C: \<0.0001\   A versus C: −24.787-−11.546; df=58\
                                                                                                 B versus C: \<0.0001    B versus C: −50.57-−35.23; df=58

   Median (IQR)          139.5 (137-150)         120 (112.5-129.5)       165 (148-174.75)                                

  Range                  132-167                 81-140                  122-185                                         

  15 min                                                                                                                 

  Mean±SD                141.13±9.59             115.93±14.11            156.7±14.23             0.751\                  ANOVA; *F*=0.287; df=87\
                                                                                                 A versus B: 0.527\      A versus B: −4.462-8.595; df=58\
                                                                                                 A versus C: 0.99\       A versus C: −5.322-5.389; df=58\
                                                                                                 B versus C: 0.551       B versus C: −8.834-4.768; df=58

   Median (IQR)          141 (134-145.75)        118 (105.25-125.5)      156.5 (145.5-166.75)                            

  Range                  127-164                 81-138                  129-180                                         

  30 min                                                                                                                 

  Mean±SD                138.33±9.46             116.3±13.1              150±13.3                \<0.0001\               ANOVA; *F*=60.166; df=87\
                                                                                                 A versus B: \<0.0001\   A versus B: 16.127-27.94; df=58\
                                                                                                 A versus C: 0.0002\     A versus C: −17.632-−5.701; df=58\
                                                                                                 B versus C: \<0.0001    B versus C: −40.523-−26.877; df=58

   Median (IQR)          138.5 (132.25-142)      115 (108.5-124)         151 (142-158)                                   

  Range                  120-170                 88-144                  111-172                                         

  45 min                                                                                                                 

  Mean±SD                133.3±10.19             114.27±14.93            145.33±11.32            \<0.0001\               ANOVA; *F*=48.564; df=87\
                                                                                                 A versus B: \<0.0001\   A versus B: 12.41-25.657; df=58\
                                                                                                 A versus C: 0.0001\     A versus C: −17.598-−6.469; df=58\
                                                                                                 B versus C: \<0.0001    B versus C: −37.913-−24.22; df=58

   Median (IQR)          134 (127.25-138)        112.5 (106.5-127.25)    145 (139-155)                                   

  Range                  113-165                 80-139                  118-166                                         

  Exsufflation                                                                                                           

  Mean±SD                125.3±11.13             113.13±15.02            128.1±14.1              0.0001\                 ANOVA; *F*=10.39; df=87\
                                                                                                 A versus B: 0.0008\     A versus B: 5.321-19.012; df=58\
                                                                                                 A versus C: 0.396\      A versus C: −9.366-3.766; df=58\
                                                                                                 B versus C: 0.0002      B versus C: −22.496-−7.437; df=58

   Median (IQR)          126 (118.5-132)         110.5 (101.25-125.25)   127 (118-139.75)                                

  Range                  108-162                 89-138                  98-154                                          

  Extubation                                                                                                             

  Mean±SD                118.53±11.04            112.97±15.15            119.5±11.42             0.104\                  ANOVA; *F*=2.322; df=87\
                                                                                                 A versus B:0.109\       A versus B: −1.285-12.419; df=58\
                                                                                                 A versus C: 0.740\      A versus C: −6.771-4.838; df=58\
                                                                                                 B versus C: 0.064       B versus C: −13.467-0.4; df=58

   Median (IQR)          121.5 (112.25-123.75)   111 (102.5-123)         121.5 (112.25-129.5)                            

  Range                  98-148                  84-142                  98-136                                          

  Postoperative 10 min                                                                                                   

  Mean±SD                115.43±11.67            112.87±14.55            115.07±8.23             0.66\                   ANOVA; *F*=0.417; df=87\
                                                                                                 A versus B: 0.453\      A versus B: −4.248\--9.381; df=58\
                                                                                                 A versus C: 0.888\      A versus C: −4.852-5.585; df=58\
                                                                                                 B versus C: 0.474       B versus C: −8.343-3.943; df=58

   Median (IQR)          116 (105-123.5)         113 (103.25-122.75)     114.5 (110-122)                                 

  Range                  94-139                  81-144                  96-127                                          
  ------------------------------------------------------------------------------------------------------------------------------------------------------------

SBP=Systolic blood pressure, SD=Standard deviation, IQR=Interquartile range, CI=Confidence interval

The values of DBP at preinduction, after giving premedication and at the time of induction were comparable between three groups with no significant difference. There was statistically significant difference in DBP during laryngoscopy and intubation between Group A and Group B and Group B and Group C. There was statistically significant difference in DBP during insufflation and during intraoperative period between Group A and Group C, Group B and Group C and Group A and Group B. There was no statistically significant difference in DBP at time of exsufflation, extubation between Group A and Group C whereas DBP was significantly lower in Group B when compared with Group A and Group C at the time of exsufflation and extubation \[[Table 4](#T4){ref-type="table"}\].

###### 

Comparison of diastolic blood pressure (mmHg) between Groups A, B and C

  -----------------------------------------------------------------------------------------------------------------------------------------------
  DBP (mmHg)             A (*n*=30)           B (*n*=30)         C (*n*=30)          *P*                     95% CI
  ---------------------- -------------------- ------------------ ------------------- ----------------------- ------------------------------------
  Preoperative                                                                                               

   Mean±SD               77.57±8.19           78.87±8.77         76.03±7.71          0.414\                  ANOVA; *F*=0.89; df=87\
                                                                                     A versus B: 0.555\      A versus B: −5.684-3.084; df=58\
                                                                                     A versus C: 0.458\      A versus C: −2.577-5.644; df=58\
                                                                                     B versus C: 0.189       B versus C: −1.434-7.101; df=58

   Median (IQR)          78 (72-81)           77.5 (72.5-85.5)   74.5 (71.25-80)                             

   Range                 60-96                62-96              64-97                                       

  Premedication                                                                                              

   Mean±SD               76.33±9.46           78.63±8.74         74.83±8.57          0.257\                  ANOVA; *F*=1.377; df=87\
                                                                                     A versus B: 0.332\      A versus B: −7.008-2.408; df=58\
                                                                                     A versus C: 0.522\      A versus C: −3.167-6.167; df=58\
                                                                                     B versus C: 0.094       B versus C: −0.676-8.276; df=58

   Median (IQR)          76.5 (70-82)         76 (72.25-86.25)   74 (69.25-78)                               

   Range                 60-102               64-97              64-104                                      

  Induction                                                                                                  

   Mean±SD               79.1±9.93            75.2±10.08         76.57±9.62          0.304\                  ANOVA; *F*=1.205; df=87\
                                                                                     A versus B: 0.136\      A versus B: −1.27-9.07; df=58\
                                                                                     A versus C: 0.319\      A versus C: −2.517-7.584; df=58\
                                                                                     B versus C: 0.593       B versus C: −6.458-3.725; df=58

   Median (IQR)          77.5 (72.5-83.75)    73.5 (70-81.5)     74.5 (71.25-81)                             

   Range                 59-104               58-99              65-102                                      

  Laryngoscopy                                                                                               

   Mean±SD               92.37±8.87           85.63±11.72        92.9±10.95          0.015\                  ANOVA; *F*=4.396; df=87\
                                                                                     A versus B: 0.014\      A versus B: 1.361-12.105; df=58\
                                                                                     A versus C: 0.836\      A versus C: −5.682-4.615; df=58\
                                                                                     B versus C: 0.016       B versus C: −13.128-−1.405; df=58

   Median (IQR)          90 (88-95)           86 (80-91.5)       90 (88-99.75)                               

   Range                 80-114               49-116             66-114                                      

  1 min                                                                                                      

   Mean±SD               86.47±10.23          82.5±10.83         87.97±10.03         0.114\                  ANOVA;*F*=2.226; df=87\
                                                                                     A versus B: 0.150\      A versus B: −1.478-9.411; df=58\
                                                                                     A versus C: 0.568\      A versus C: −6.735-3.735; df=58\
                                                                                     B versus C: 0.047       B versus C: −10.862-−0.071; df=58

   Median (IQR)          85 (80.25-91.75)     85 (78.5-89)       88 (84-93.75)                               

   Range                 66-110               56-100             56-110                                      

  5 min                                                                                                      

   Mean±SD               79.77±9.92           76.87±11.82        79.47±12.34         0.558\                  ANOVA; *F*=0.586; df=87\
                                                                                     A versus B: 0.307\      A versus B: −2.738-8.538; df=58\
                                                                                     A versus C: 0.917\      A versus C: −5.486-6.086; df=58\
                                                                                     B versus C: 0.408       B versus C: −8.844-3.644; df=58

   Median (IQR)          79 (73.25-84)        79 (70-85.5)       81 (76-87)                                  

   Range                 62-106               42-90              42-106                                      

  15 min                                                                                                     

   Mean±SD               78.63±8.58           74.47±11.19        76.8±10.44          0.284\                  ANOVA; *F*=1.275; df=87\
                                                                                     A versus B: 0.111\      A versus B: −0.988-9.321; df=58\
                                                                                     A versus C: 0.460\      A versus C: −3.105-6.772; df=58\
                                                                                     B versus C: 0.407       B versus C: −7.927-3.261; df=58

   Median (IQR)          79.5 (74.5-83)       76 (69.5-80.75)    77.5 (73.25-82.5)                           

   Range                 55-100               41-92              41-100                                      

  Insufflation                                                                                               

   Mean±SD               96.2±7.05            73.7±10.61         101.43±8.52         \<0.0001\               ANOVA; *F*=83.187; df=87\
                                                                                     A versus B: \<0.0001\   A versus B: 17.845-27.155; df=58\
                                                                                     A versus C: 0.012\      A versus C: −9.277-−1.19; df=58\
                                                                                     B versus C: \<0.0001    B versus C: −32.706-−22.76; df=58

   Median (IQR)          97.5 (88.75-99.75)   76 (69.25-80)      99 (98-107.75)                              

   Range                 83-111               43-90              79-120                                      

  5 min                                                                                                      

   Mean±SD               95.53±6.04           71.2±10.97         101.3±8.09          \<0.0001\               ANOVA; *F*=103.39; df=87\
                                                                                     A versus B: \<0.0001\   A versus B: 19.73-28.937; df=58\
                                                                                     A versus C: 0.002\      A versus C: −9.456-−2.077; df=58\
                                                                                     B versus C: \<0.0001    B versus C: −35.079-−25.121; df=58

   Median (IQR)          96 (92.25-98.75)     73 (64.5-77.5)     102 (94.5-107.75)                           

   Range                 83-111               44-92              81-116                                      

  15 min                                                                                                     

   Mean±SD               92.4±6.09            69.13±11.49        99.57±7.74          0.284\                  ANOVA; *F*=1.275; df=87\
                                                                                     A versus B: 0.111\      A versus B: −0.988-9.321; df=58\
                                                                                     A versus C: 0.46\       A versus C: −3.105-6.772; df=58\
                                                                                     B versus C: 0.407       B versus C: −7.927-3.261; df=58

   Median (IQR)          93 (89-95.75)        70 (64.25-75.5)    98 (95.25-106.75)                           

   Range                 82-107               44-90              77-114                                      

  30 min                                                                                                     

   Mean±SD               89.53±4.9            69.7±10            96.87±7.07          \<0.0001\               ANOVA; *F*=102.104; df=87\
                                                                                     A versus B: \<0.0001\   A versus B: 15.73-23.937; df=58\
                                                                                     A versus C: \<0.0001\   A versus C: −10.479-−4.187; df=58\
                                                                                     B versus C: \<0.0001    B versus C: −31.644-−22.69; df=58

   Median (IQR)          90 (87-91)           70 (62.5-75.75)    97.5 (93-101.75)                            

   Range                 80-102               47-89              75-108                                      

  45 min                                                                                                     

   Mean±SD               85.33±5.33           68.67±11.87        93.93±6.14          \<0.0001\               ANOVA; *F*=71.747; df=87\
                                                                                     A versus B: \<0.0001\   A versus B: 11.865-21.468; df=58\
                                                                                     A versus C: \<0.0001\   A versus C: −11.569-−5.631; df=58\
                                                                                     B versus C: \<0.0001    B versus C: −30.186-−20.347; df=58

   Median (IQR)          85 (83-87)           72 (60.5-76)       94.5 (90-97.75)                             

   Range                 75-101               42-88              76-104                                      

  Exsufflation                                                                                               

   Mean±SD               79.63±6.33           70.13±10.44        83.3±10.9           \<0.0001\               ANOVA; *F*=15.509; df=87\
                                                                                     A versus B: 0.0001\     A versus B: 5.016-13.984; df=58\
                                                                                     A versus C: 0.116\      A versus C: −8.273-0.94; df=58\
                                                                                     B versus C: \<0.0001    B versus C: −18.683-−7.65; df=58

   Median (IQR)          80.5 (75.25-83)      71 (62-76.75)      83 (77-89.5)                                

   Range                 66-92                48-92              48-102                                      

  Extubation                                                                                                 

   Mean±SD               75.17±7.51           70.17±10.4         76.83±9.44          0.017\                  ANOVA; *F*=4.271; df=87\
                                                                                     A versus B: 0.037\      A versus B: 0.312-9.688; df=58\
                                                                                     A versus C: 0.452\      A versus C: −6.075-2.742; df=58\
                                                                                     B versus C: 0.011       B versus C: −11.799-−1.534; df=58

   Median (IQR)          76.5 (70-80)         70 (64-78)         77.5 (70.5-82)                              

   Range                 60-90                50-90              50-95                                       

  Postoperative 10 min                                                                                       

   Mean±SD               71.33±9.64           69.5±9.88          71.93±7.05          0.55\                   ANOVA; *F*=0.602; df=87\
                                                                                     A versus B: 0.47\       A versus B: −3.213-6.879; df=58\
                                                                                     A versus C: 0.784\      A versus C: −4.965-3.765; df=58\
                                                                                     B versus C: 0.276       B versus C: −6.869-2.002; df=58

   Median (IQR)          70.5 (65.25-77.75)   70 (62-78)         72.5 (68-76)                                

   Range                 54-92                50-88              55-85                                       
  -----------------------------------------------------------------------------------------------------------------------------------------------

SD=Standard deviation, IQR=Interquartile range, CI=Confidence interval, DBP=Diastolic blood pressure

The values of mean blood pressure at preinduction, after giving premedication and at the time of induction were comparable between three groups with no significant difference. There was statistically significant difference in MBP during laryngoscopy and intubation between Group A and Group B and Group B and Group C. There was statistically significant difference in MBP during insufflation and during intraoperative period between Group A and Group C, Group B and Group C and Group A and Group B. There was no statistically significant difference in MBP at time of exsufflation, extubation and in postoperative period between Group A and Group C whereas MBP was significantly lower in Group B when compared with Group A and Group C at the time of exsufflation and extubation \[[Table 5](#T5){ref-type="table"}\].

###### 

Comparison of mean arterial pressure (mmHg) between Groups A, B and C

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------
  MAP (mmHg)             A (*n*=30)                 B (*n*=30)                C (*n*=30)                 *P*                     95% CI; df
  ---------------------- -------------------------- ------------------------- -------------------------- ----------------------- -------------------------------------
  Preoperative                                                                                                                   

   Mean±SD               93.03±8.7                  95.68±10.16               92.24±7.97                 0.306\                  ANOVA; *F*=1.2; df=87\
                                                                                                         A versus B: 0.283\      A versus B: −7.534-2.245; df=58\
                                                                                                         A versus C: 0.715\      A versus C: −3.524-5.102; df=58\
                                                                                                         B versus C: 0.150       B versus C: −1.287-8.154; df=58

   Median (IQR)          92 (87.333-97.917)         93.67 (89.917-101.833)    91.5 (86.333-97.083)                               

   Range                 76.67-111.33               72.33-116.67              76-111.33                                          

  Premedication                                                                                                                  

   Mean±SD               92.09±10.13                95.31±10.15               91.14±9.5                  0.239\                  ANOVA; *F*=1.453; df=87\
                                                                                                         A versus B: 0.223\      A versus B: −8.461-2.016; df=586\
                                                                                                         A versus C: 0.710\      A versus C: −4.129-6.017; df=58\
                                                                                                         B versus C: 0.105       B versus C: −0.912-9.245; df=58

   Median (IQR)          93 (84-97.167)             95.33 (87.417-100.833)    90.83 (83.75-95.833)                               

   Range                 76.67-119                  75-120.33                 76.67-121                                          

  Induction                                                                                                                      

   Mean±SD               93.86±9.74                 90.59±10.59               91.23±9.34                 0.403\                  ANOVA; *F*=0.916; df=87\
                                                                                                         A versus B: 0.218\      A versus B: −1.99-8.524; df=58\
                                                                                                         A versus C: 0.291\      A versus C: −2.308-7.553; df=58\
                                                                                                         B versus C: 0.803       B versus C: −5.804-4.515; df=58

   Median (IQR)          93.33 (86.417-98.667)      89.33 (84.833-97.167)     90.67 (83.5-95.75)                                 

   Range                 76-120                     68-114                    80.33-116                                          

  Laryngoscopy                                                                                                                   

   Mean±SD               109.17±9.37                101.51±12.17              109.37±11.37               0.009\                  ANOVA; *F*=4.944; df=87\
                                                                                                         A versus B: 0.008\      A versus B: 2.043-13.268; df=58\
                                                                                                         A versus C: 0.941\      A versus C: −5.584-5.184; df=58\
                                                                                                         B versus C: 0.012       B versus C: −13.942-−−1.769; df=58

   Median (IQR)          106.67 (104.083-112.5)     103.67 (94-107.667)       106.67 (104.167-115.167)                           

   Range                 94.67-131.33               61-131                    81-133.33                                          

  1 min                                                                                                                          

   Mean±SD               103.79±9.95                99.32±11.45               104.72±10.64               0.118                   ANOVA; *F*=2.183; df=87

                                                                                                         A versus B: 0.112\      A versus B: −1.078-10.012; df=58\
                                                                                                         A versus C: 0.726\      A versus C: −6.257-4.391; df=58\
                                                                                                         B versus C:0.063        B versus C: −11.113-0.313; df=58

   Median (IQR)          102.33 (97.167-108.667)    102.67 (93.833-106.333)   104.33 (100.333-108.583)                           

   Range                 88.33-132                  71.33-121.33              71.33-132                                          

  5 min                                                                                                                          

   Mean±SD               96.63±9.33                 93.46±12.77               95.89±11.86                0.531\                  ANOVA; *F*=0.636; df=87\
                                                                                                         A versus B: 0.275\      A versus B: −2.601-8.957; df=58\
                                                                                                         A versus C: 0.787\      A versus C: −4.769-6.258; df=58\
                                                                                                         B versus C: 0.447       B versus C: −8.802-3.935; df=58

   Median (IQR)          96 (88.833-102.167)        95.67 (89.5-101.917)      97.33 (92.083-101.167)                             

   Range                 82.67-117.33               55.33-111                 55.33-117.33                                       

  15 min                                                                                                                         

   Mean±SD               94.1±7.95                  90.63±12.09               92.87±9.89                 0.408\                  ANOVA; *F*=0.905; df=87\
                                                                                                         A versus B: 0.194\      A versus B: −1.82-8.753; df=58\
                                                                                                         A versus C: 0.596\      A versus C: −3.403-5.869; df=58\
                                                                                                         B versus C: 0.436       B versus C: −7.94-3.473; df=58

   Median (IQR)          95 (90.417-98.083)         91.67 (87.583-97.167)     93.33 (89-98.083)                                  

   Range                 75-112                     53.33-109.33              60.33-112                                          

  Insufflation                                                                                                                   

   Mean±SD               112.03±6.73                89.49±10.73               121.53±10.11               \<0.0001\               ANOVA; *F*=92.83; df=87\
                                                                                                         A versus B: \<0.0001\   A versus B: 17.916-27.173; df=58
                                                                                                         A versus C: 0.0001\     
                                                                                                         B versus C: \<0.0001    

   Median (IQR)          111.5 (107.333-115.5)      90.33 (84.917-95.917)     120.5 (114.667-129.333)                            

   Range                 100.33-132                 61-107.33                 98.67-147.33                                       

                                                                                                                                 A versus C: −13.953-−5.047; df=58\
                                                                                                                                 B versus C: −37.432-−26.657; df=58

  5 min                                                                                                                          

   Mean±SD               111.49±6.17                87.02±11.47               121.39±9.49                \<0.0001\               ANOVA; *F*=108.42; df=87\
                                                                                                         A versus B: \<0.0001\   A versus B: 19.675-29.258; df=58\
                                                                                                         A versus C: \<0.0001\   A versus C: −14.053-−5.747; df=58\
                                                                                                         B versus C: \<0.0001    B versus C: −39.808-−−28.925; df=58

   Median (IQR)          110.67 (107.583-114.667)   87.5 (81.917-93.667)      123.83 (114.5-128.333)                             

   Range                 101.33-129.67              56.33-108                 94.67-135.67                                       

  15 min                                                                                                                         

   Mean±SD               108.64±6.19                84.73±11.86               118.61±8.78                0.408\                  ANOVA; *F*=0.905; df=87\
                                                                                                         A versus B: 0.194\      A versus B: −1.82-8.753; df=58\
                                                                                                         A versus C: 0.596\      A versus C: −3.403-5.869; df=58\
                                                                                                         B versus C: 0.436       B versus C: −7.94-3.473; df=58

   Median (IQR)          108.67 (104.75-111.917)    85 (78.417-90.667)        119.33 (113.583-124)                               

   Range                 97-126                     56.33-106                 94.33-136                                          

  30 min                                                                                                                         

   Mean±SD               105.8±5.87                 85.23±10.74               114.58±8.17                \<0.0001\               ANOVA; *F*=94.27; df=87\
                                                                                                         A versus B: \<0.0001\   A versus B: 16.065-25.068; df=58\
                                                                                                         A versus C: \<0.0001\   A versus C: −12.454-−5.101; df=58\
                                                                                                         B versus C: \<0.0001    B versus C: −34.276-−24.413; df=58

   Median (IQR)          105.33 (103.75-108.25)     84.83 (77.333-91.167)     115.83 (109.667-120.25)                            

   Range                 96.33-124.67               60.67-107.33              92.33-127                                          

  45 min                                                                                                                         

   Mean±SD               101.32±6.39                83.87±12.57               111.07±6.71                \<0.0001\               ANOVA; *F*=70.102; df=87\
                                                                                                         A versus B: \<0.0001\   A versus B: 12.264-22.647; df=58\
                                                                                                         A versus C: \<0.0001\   A versus C: −13.13-−6.359; df=58\
                                                                                                         B versus C: \<0.0001    B versus C: −32.441-−21.959; df=58

   Median (IQR)          101.5 (98.167-103.5)       84 (77-93)                112.33 (106.667-115.333)                           

   Range                 88-122.33                  57.33-105                 94-121.33                                          

  Exsufflation                                                                                                                   

   Mean±SD               94.86±6.83                 84.47±11.39               98.23±11.05                \<0.0001\               ANOVA; *F*=15.529; df=87\
                                                                                                         A versus B: 0.0001\     A versus B: 5.513-15.264; df=58\
                                                                                                         A versus C: 0.160\      A versus C: −8.144-1.389; df=58\
                                                                                                         B versus C: \<0.0001    B versus C: −19.565-−7.969; df=58

   Median (IQR)          95.83 (89.25-99.333)       83.17 (76.75-93.25)       96.5 (92-107.833)                                  

   Range                 84.67-115.33               64.67-107                 64.67-114.33                                       

  Extubation                                                                                                                     

   Mean±SD               89.62±7.94                 84.43±11.32               91.06±8.55                 0.019\                  ANOVA; *F*=4.133; df=87\
                                                                                                         A versus B: 0.044\      A versus B: 0.136-10.242; df=58\
                                                                                                         A versus C: 0.503\      A versus C: −5.698-2.831; df=58\
                                                                                                         B versus C: 0.013       B versus C: −11.808-−1.437; df=58

   Median (IQR)          90.17 (84.083-95.167)      83.67 (78.167-93)         90.33 (86-96.25)                                   

   Range                 74.67-109.33               63.67-107.33              67.33-107.33                                       

  Postoperative 10 min                                                                                                           

   Mean±SD               86.03±9.49                 83.96±10.64               86.31±5.57                 0.531\                  ANOVA; *F*=0.636; df=87\
                                                                                                         A versus B: 0.428\      A versus B: −3.133-7.289; df=58\
                                                                                                         A versus C: 0.890\      A versus C: −4.321-3.766; df=58\
                                                                                                         B versus C: 0.288       B versus C: −6.775-2.064; df=58

   Median (IQR)          86 (78.833-93.333)         83.83 (78.75-90)          86.5 (83.667-89.75)                                

   Range                 70.33-107.67               60.33-104.67              71-96.33                                           
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

The hemodynamic responses to laryngoscopy and laparoscopy, comprising of elevation in HR and rise in systolic and DBP, are well known. It has become imperative to develop a novel technique/drug to prevent these potentially hazardous responses.\[[@ref3]\]

The drugs for controlling these hemodynamic responses aim to stabilize HR and blood pressure during laryngoscopy and laparoscopy. Safety of such drugs is also a prime concern.

In the present study, we found that both pregabalin or clonidine are effective in maintaining the hemodynamic stability during laryngoscopy and LC with minimal side effects, with clonidine providing a better hemodynamic stability than Pregabalin.

All patients selected in the study belonged to the age between 18 and 55 years. The mean age of patients in group A, B, and C were 40.8 years, 38.4 years, and 39.4 years, respectively. There was no statistically significant difference of age among the three groups (*P* \> 0.05). In all the three groups, the majority of the patients belonged to the age group 41--56 years. The three groups were evenly matched with respect to age. This has helped us to judge the clinical significance of our study as the distribution, metabolism, excretion and action of the drug are undoubtedly varied in different age groups. Therefore, clinically insignificant variation in age simply helped to alleviate these confounding factors. All of the three groups were statistically similar with regard to the sex distribution of the patients. Hence, gender was not the confounding factor in the analysis of results.

In this study, all three groups had a majority of patients in the ASA Grade 1. Patients with ASA Grade 3 and Grade 4 were excluded from the study. The groups were similar in terms of ASA grade also. Therefore, our study was conducted mostly on fit patients having no systemic illness, and there was no systemic disease significantly altering the drug metabolism in patients selected for the study.

All patients in control Group C were anxious before induction, while patients in the pregabalin Group A and the clonidine Group B were sedated and showed decrease in anxiety as compared to control Group C. Preoperative anxiolysis and sedation were higher in oral pregabalin Group A as compared with clonidine Group B.

The mean baseline pulse rate, SBP, DBP, and MBP were similar in all the groups. The comparability of the baseline characteristics in a randomized controlled trial ensures that the outcome is purely linked to the intervention and is not a chance effect as was seen in our study.

On monitoring the stages of preparation, intubation and surgery, we found that the hemodynamic variability was more pronounced during laryngoscopy and intubation among the control population, with a higher HR, SBP, DBP, and MBP as compared to both intervention groups which returned to normal within 15 min. The second variability was noted during insufflation of CO~2~ gas and throughout the period of pneumoperitoneum. Although the intra-abdominal pressure is continuously monitored during the insufflation and is tried to be kept as low as possible; still the rise in HR and BP becomes unavoidable. The rise in the hemodynamic parameters was significantly attenuated in the clonidine group than pregabalin and control group. Clonidine provided better hemodynamic stability with least rise in HR and blood pressures during various procedures involved in the surgery and even at extubation and in the postoperative period as compared to both the control group and pregabalin group. Our findings are in line with various previous studies who compared clonidine and pregabalin or control population and found a significantly better hemodynamic stabilization with Clonidine.\[[@ref9][@ref10]\] Even, the time periods at which the HR and BP were significantly different among the intervention groups were mostly similar. Gupta *et al*.,\[[@ref17]\] reported hemodynamic variability after laryngoscopy with maximal rise after 1 min of laryngoscopy in the control population. They reported a statistically significant attenuation of HR and BM in premedicated groups (*P* \< 0.0001), with clonidine showing better stabilization than pregabalin. In a study by Parveen *et al*.,\[[@ref10]\] at all the observation periods, HR and BP of clonidine group was lower than that of pregabalin group.

The successful attenuation of the stress response with clonidine and pregabalin at the major events of laryngoscopy, intubation, insufflation and extubation, minimizes the risk of an adverse cardiac event during the routine surgery of LC especially in elderly and hemodynamically compromised patients. As clonidine showed a better response than pregabalin; it holds a clinical relevance for its use in routine practice as it provided the better efficacy and minimal side effects.

The administration of clonidine must be cautioned for dosage as it shown varied response at different doses (2--5 ug/kg) as shown in different studies.\[[@ref11][@ref12][@ref13]\] Higher dose of clonidine (5 ug/kg) is usually required for potentiation of postoperative analgesia by intrathecal morphine whereas a small oral dose of clonidine decreased the incidence of perioperative myocardial ischemic episodes without affecting hemodynamic stability. Mrinmoy *et al*. stressed on a dose of 150 ug as a good standard dose for reducing hemodynamic changes during the operation.\[[@ref3]\]

Another clinical relevance of the use of clonidine would be the decreased need for isoflurane and antihypertensives such as esmolol during the surgery as clonidine serves with a multipurpose function due to its varied mechanisms of sympathetic antagonist and antihypertensive. In addition, it also helps prevent certain other complication during the surgery such as perioperative shivering by inhibiting cold thermoregulatory response, and nausea/vomiting by increasing gastrointestinal motility by decreasing sympathetic outflow and increasing parasympathetic out-flow from the central nervous system. This antiemetic property needs clarification of the mechanism from the future studies.

The study holds strength in being a randomized controlled trial comparing two drugs at a time and the results hold clinical significance to propose the routine use of clonidine in a common surgery (LC).

The study suffers from the limitation in not comparing the different doses of clonidine. And in the newer setups, conventional 4-port LC is being replaced by 3-port and single port LC; thus, the use of clonidine also needs to be explored in the modified versions of LC which was not done in the current study.

C[ONCLUSION]{.smallcaps} {#sec1-5}
========================

Oral premedication with pregabalin (150 mg) and clonidine (200 mcg) are effective in attenuation of the sympathomimetic response to laryngoscopy and laparoscopy with clonidine providing better hemodynamic stability than Pregabalin.
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